Divis Labs Q2 PAT seen up 45.7% YoY to Rs. 290 cr: HDFC Securities

Net Sales are expected to increase by 15 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 1,020 crore, according to HDFC Securities.

October 17, 2018 / 05:59 PM IST
Pharma

Pharma

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

HDFC Securities has come out with its second quarter (July-September’ 18) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Divis Labs to report net profit at Rs. 290 crore up 45.7% year-on-year (up 19.4% quarter-on-quarter).


Net Sales are expected to increase by 15 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 1,020 crore, according to HDFC Securities.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 37.3 percent Y-o-Y (up 8.2 percent Q-o-Q) to Rs. 380 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Moneycontrol News

stay updated

Get Daily News on your Browser
Sections